Point72 Asset Management's 13G Filing for Replimune Group, Inc.

SEC Filing SCHEDULE 13G (0000902664-25-003286)

Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen have jointly filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 5.7% of the common stock of Replimune Group, Inc. The filing, dated July 31, 2025, indicates that Point72 Asset Management maintains investment and voting power over the shares held by Point72 Associates, LLC. Point72 Capital Advisors, Inc. is the general partner of Point72 Asset Management, and Steven A. Cohen controls both entities. The filing is made pursuant to Rule 13d-1(c) of the Securities Exchange Act of 1934, and the parties have entered into a Joint Filing Agreement. The shares are held for investment purposes and not for the purpose of influencing the control of Replimune Group, Inc.